Compare Cassava Sciences Inc (FLNA) vs iShares Russell 2000 ETF (IWM) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

IWM trades at $295.80, up 0.46% with a bullish technical signal from moving averages. The ETF has gained 22.1% year-to-date, outperforming large-cap benchmarks. Recent news highlights small-cap strength amid shifting rate expectations, though some analysts warn of valuation traps. Support sits at $294 with resistance at $297.

Outlook remains positive for small-cap exposure if economic expansion continues, but risks include higher volatility and sensitivity to interest rates. The expense ratio of 0.19% compares to peers, and dividend yield is minimal. Investors should weigh growth potential against inherent small-cap risks.